Estrogens, Conjugated

CAS 12126-59-9 2 current records 3 historicalOther

Who holds supplier records for Estrogens, Conjugated? 2 organisations hold a current record for Estrogens, Conjugated: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: United States (1) and China (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Estrogens, Conjugated: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/estrogens-conjugated

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • No company-level GMP certificate matched

    No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Estrogens, Conjugated. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Estrogens, Conjugated sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (3)

Organisations whose Type II DMFs for Estrogens, Conjugated are no longer active. These show a past filing, not current supply.

Show all 3 historical records
  • PLANTEX LTD CHEMICAL AND PHARMACEUTICAL WORKS
    Inactive DMF 3011 · filed Aug 1977
  • United States · Inactive DMF 2774 · filed Oct 1976
  • AYERST LABORATORIES INC DIV AMERICAN HOME PRODUCTS CORP
    Inactive DMF 934 · filed Dec 1965

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (12 listed products contain Estrogens, Conjugated). The latest listed exclusivity ended 15 Apr 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Estrogens, Conjugated is a unknown active pharmaceutical ingredient (ChEMBL CHEMBL1201649).

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Estrogen
Mechanism of action
Estrogen Receptor Agonists
Chemical structure
Conjugated (USP)

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Estrogens, Conjugated?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Estrogens, Conjugated: Padagis US LLC (United States) and XINJIANG NUZILINE BIO PHARMACEUTICAL CO LTD (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Estrogens, Conjugated Drug Master Files are active?

Padagis US LLC (DMF 14046) and XINJIANG NUZILINE BIO PHARMACEUTICAL CO LTD (DMF 29827, 25337). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Estrogens, Conjugated records mean?

3 organisations have only inactive Type II DMFs for Estrogens, Conjugated. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Estrogens, Conjugated supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Estrogens, Conjugated?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.